Plantar Fasciitis Treatment Global Market Report 2024: Key Players, Demand Patterns And Forecasts 2033 | Bayer AG, Superfeet Worldwide LLC, Bauerfeind AG, Ottobock SE & Co. KGaA

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2592

The Business Research Company offers in-depth market insights through Plantar Fasciitis Treatment Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The plantar fasciitis treatment market size has grown exponentially in recent years. It will grow from $1.34 billion in 2023 to $1.67 billion in 2024 at a compound annual growth rate (CAGR) of 24.4%. The growth in the historic period can be attributed to alternative therapies, patient education and awareness, pain management solutions, rise in sports injuries, physical therapy techniques..

The plantar fasciitis treatment market size is expected to see exponential growth in the next few years. It will grow to $3.82 billion in 2028 at a compound annual growth rate (CAGR) of 23.1%. The growth in the forecast period can be attributed to regulatory changes and approvals, patient-centric approaches, research and clinical trials, focus on personalized medicine, growing aging population.. Major trends in the forecast period include focused rehabilitation techniques, innovations in orthopedic devices, biomechanical studies, alternative therapies advancements, patient education and self-care..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=9385&type=smp

Market Segmentation:
The plantar fasciitis treatment market covered in this report is segmented -

1) By Type: Medication Therapy, Orthotics, Shockwave Therapy, Surgery, Other Types
2) By Diagnosis: Medical History, Physical Examination, X-Rays, Radiography, Other Diagnosis
3) By End User: Hospitals, Clinics, Other End Users

Major Driver - Obesity Propels Growth In The Plantar Fasciitis Market
A rise in obesity is expected to propel the growth of the plantar fasciitis market going forward. Obesity is a health risk caused by an abnormal or excessive fat buildup. Overweight is defined as a body mass index (BMI) of 25 or greater and obesity as a BMI greater than 30. A person with a normal weight has a chance of acquiring plantar fasciitis that is almost six times lower than that of someone with a body mass index (BMI) of 30 or higher. For instance, in January 2023, according to a report shared by Forbes, a US-based business magazine, During the COVID-19 pandemic, the obesity rate in the United States increased by 3% between March 2020 and March 2021. Therefore, the rise in obesity is driving the growth of the plantar fasciitis market.

Competitive Landscape:
Major companies operating in the plantar fasciitis treatment market report are Bayer AG, Superfeet Worldwide LLC, Bauerfeind AG, Ottobock SE & Co. KGaA, Shapecrunch Technology Pvt. Ltd., Sanofi SA, Eli Lilly and Company, GlaxoSmithKline plc, Pfizer Inc., Allergan plc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Scholl's Wellness Co., Algeo Limited, Hanger Inc., Merck & Co. Inc., Novartis AG, Johnson & Johnson Services Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., DJO Global Co., Medline Industries Inc., Bird & Cronin Inc., Hoya Corp., Aetrex Worldwide Inc., Vionic Group LLC .

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/plantar-fasciitis-treatment-global-market-report

Top Trend - Technological Advancements In Plantar Fasciitis Treatment Market
Technological advancements are a key trend gaining popularity in the plantar fasciitis treatment market. Major companies operating in the plantar fasciitis treatment market are developing and implementing new technologies to revolutionize treatment for plantar heel pain and expanding their geographic presence to sustain their position in the market. For instance, in December 2022, ZetrOZ Systems, a US-based ultrasound technology manufacturing company, introduced the Sam X1, the only wireless ultrasound device with FDA certification for at-home usage. The Sam X1 wireless unit can be used as a regenerative treatment alternative for soft tissue injuries and plantar fasciitis to boost cellular proliferation without the use of drugs or surgery. It has been proven effective in treating a wide range of injuries, including plantar fasciitis. The ZetrOZ sam x1 device widens blood vessels to deliver more oxygenated blood to the healing region, eliminating waste products such as cytokine enzymes and cells, and speeding up the healing process.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Plantar Fasciitis Treatment Market Characteristics
3. Plantar Fasciitis Treatment Market Trends And Strategies
4. Plantar Fasciitis Treatment Market - Macro Economic Scenario
5. Plantar Fasciitis Treatment Market Size And Growth
…..
27. Plantar Fasciitis Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries

This release was published on openPR.